UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Insulin stacking versus therapeutic accumulation: understanding the differences

Endocrine practice, 2014-01, Vol.20 (1), p.75-83

2014

Volltextzugriff (PDF)

Intensifying Insulin Therapy: What Options Are Available to Patients with Type 2 Diabetes?

The American journal of medicine, 2013-09, Vol.126 (9), p.S28-S37

Meneghini, Luigi F., MD, MBA

2013

Volltextzugriff (PDF)

Early Insulin Treatment in Type 2 Diabetes: What are the pros?

Diabetes care, 2009-11, Vol.32 (Suppl 2), p.S266-S269

Meneghini, Luigi F

2009

Volltextzugriff (PDF)

Impact of delaying treatment intensification with a glucagon‐like peptide‐1 receptor agonist in patients with type 2 diabetes uncontrolled on basal insulin: A longitudinal study of a US administrative claims database

Diabetes, obesity & metabolism, 2018-04, Vol.20 (4), p.831-839

2018

Volltextzugriff (PDF)

Association of hypoglycaemia severity with clinical, patient‐reported and economic outcomes in US patients with type 2 diabetes using basal insulin

Diabetes, obesity & metabolism, 2018-05, Vol.20 (5), p.1156-1165

2018

Volltextzugriff (PDF)

Screening, evaluation and management of depression in people with diabetes in primary care

Primary care diabetes, 2013-04, Vol.7 (1), p.1-10

2013

Volltextzugriff (PDF)

Role of Devices in Insulin Delivery

Diabetes technology & therapeutics, 2017-02, Vol.19 (2), p.76-78

2017

Volltextzugriff (PDF)

A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 6‐month outcomes of the ACHIEVE Control study

Diabetes, obesity & metabolism, 2020-11, Vol.22 (11), p.2004-2012

2020

Volltextzugriff (PDF)

Insulin Degludec in Type 1 Diabetes: A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine

Diabetes care, 2011-03, Vol.34 (3), p.661-665

2011

Volltextzugriff (PDF)

Perioperative management of diabetes: Translating evidence into practice

Cleveland Clinic journal of medicine, 2009-11, Vol.76 (Suppl 4), p.S53-S59

Meneghini, Luigi F

2009

Volltextzugriff (PDF)

The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real‐world setting

Diabetes, obesity & metabolism, 2019-06, Vol.21 (6), p.1429-1436

2019

Volltextzugriff (PDF)

Insulin therapy for type 2 diabetes

Endocrine, 2013-06, Vol.43 (3), p.529-534

Meneghini, Luigi F.

2013

Volltextzugriff (PDF)

Barriers to Initiating Insulin in Type 2 Diabetes Patients: Development of a New Patient Education Tool to Address Myths, Misconceptions and Clinical Realities

The patient : patient-centered outcomes research, 2014, Vol.7 (4), p.437-450

2014

Volltextzugriff (PDF)

Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures

Diabetes technology & therapeutics, 2017-05, Vol.19 (5), p.315-322

2017

Volltextzugriff (PDF)

Prevalence and Associations of Binge Eating Disorder in a Multiethnic Population With Type 2 Diabetes

Diabetes care, 2006-12, Vol.29 (12), p.2760-2760

2006

Volltextzugriff (PDF)

Design and Implementation of an Electronic Tool to Measure Medication Adherence at the Point of Care

Clinical diabetes, 2020-10, Vol.38 (4), p.382-385

2020

Volltextzugriff (PDF)

Stepwise addition of prandial insulin

The lancet. Diabetes & endocrinology, 2014, Vol.2 (1), p.3-4

Meneghini, Luigi F

2014

Volltextzugriff (PDF)

A randomized trial comparing the efficacy and safety of treating patients with type 2 diabetes and highly elevated HbA1c levels with basal-bolus insulin or a glucagon-like peptide-1 receptor agonist plus basal insulin: The SIMPLE study

Diabetes, obesity & metabolism, 2019-09, Vol.21 (9), p.2133-2141

2019

Volltextzugriff (PDF)

Insulin for intensifying diabetes treatment

The Journal of family practice, 2011-09, Vol.60 (9 Suppl), p.S21-S28

Meneghini, Luigi F

2011

Volltextzugriff (PDF)

Making Inroads in Addressing Population Health in Underserved Communities With Type 2 Diabetes

Diabetes spectrum, 2019-11, Vol.32 (4), p.303-311

2019

Volltextzugriff (PDF)

Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial

Advances in therapy, 2019-09, Vol.36 (9), p.2310-2326

2019

Volltextzugriff (PDF)

Short-term intensive insulin therapy at diagnosis in type 2 diabetes: plan for filling the gaps

Diabetes/metabolism research and reviews, 2015-09, Vol.31 (6), p.537-544

2015

Volltextzugriff (PDF)

Hypoglycaemia and treatment patterns among insulin‐treated patients with type 2 diabetes who switched to insulin glargine 300 units/mL versus other basal insulin in a real‐world setting

Endocrinology, diabetes & metabolism, 2019-07, Vol.2 (3), p.e00073-n/a

2019

Volltextzugriff (PDF)

Obesity, bariatric surgery and type 2 diabetes-a systematic review

Diabetes/metabolism research and reviews, 2004-11, Vol.20 (6), p.438-445

2004

Volltextzugriff (PDF)

Effect of baseline glycosylated hemoglobin A1c on glycemic control and diabetes management following initiation of once-daily insulin detemir in real-life clinical practice

Endocrine practice, 2013-05, Vol.19 (3), p.462-470

2013

Volltextzugriff (PDF)

1 – 25 von 187

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(163)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(88)
Humans
(86)
Life Sciences & Biomedicine
(85)
Diabetes
(57)
Endocrinology & Metabolism
(56)
Diabetes Mellitus, Type 2 - Drug Therapy
(49)
Female
(46)
Male
(44)
Middle Aged
(40)
Hypoglycemic Agents - Therapeutic Use
(38)
Insulin
(37)
Type 2 Diabetes
(34)
Aged
(30)
Diabetes Mellitus
(29)
Adult
(28)
Hypoglycemia
(27)
Insulin - Therapeutic Use
(25)
Patients
(25)
Diabetes Mellitus, Type 2 - Blood
(23)
Treatment Outcome
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Insulin stacking versus therapeutic accumulation: understanding the differences

Intensifying Insulin Therapy: What Options Are Available to Patients with Type 2 Diabetes?

Early Insulin Treatment in Type 2 Diabetes: What are the pros?

Impact of delaying treatment intensification with a glucagon‐like peptide‐1 receptor agonist in patients with type 2 diabetes uncontrolled on basal insulin: A longitudinal study of a US administrative claims database

Association of hypoglycaemia severity with clinical, patient‐reported and economic outcomes in US patients with type 2 diabetes using basal insulin

Screening, evaluation and management of depression in people with diabetes in primary care

Role of Devices in Insulin Delivery

A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 6‐month outcomes of the ACHIEVE Control study

Insulin Degludec in Type 1 Diabetes: A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine

Perioperative management of diabetes: Translating evidence into practice

The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real‐world setting

Insulin therapy for type 2 diabetes

Barriers to Initiating Insulin in Type 2 Diabetes Patients: Development of a New Patient Education Tool to Address Myths, Misconceptions and Clinical Realities

Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures

Prevalence and Associations of Binge Eating Disorder in a Multiethnic Population With Type 2 Diabetes

Design and Implementation of an Electronic Tool to Measure Medication Adherence at the Point of Care

Stepwise addition of prandial insulin

A randomized trial comparing the efficacy and safety of treating patients with type 2 diabetes and highly elevated HbA1c levels with basal-bolus insulin or a glucagon-like peptide-1 receptor agonist plus basal insulin: The SIMPLE study

Insulin for intensifying diabetes treatment

Making Inroads in Addressing Population Health in Underserved Communities With Type 2 Diabetes

Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial

Short-term intensive insulin therapy at diagnosis in type 2 diabetes: plan for filling the gaps

Hypoglycaemia and treatment patterns among insulin‐treated patients with type 2 diabetes who switched to insulin glargine 300 units/mL versus other basal insulin in a real‐world setting

Obesity, bariatric surgery and type 2 diabetes-a systematic review

Effect of baseline glycosylated hemoglobin A1c on glycemic control and diabetes management following initiation of once-daily insulin detemir in real-life clinical practice

Suchergebnisse filtern